UK Markets close in 3 hrs 20 mins

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
59.62-0.47 (-0.78%)
At close: 04:00PM EDT
59.62 0.00 (0.00%)
After hours: 04:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3100.00
52-week low 350.50
50-day moving average 379.98
200-day moving average 382.08

Share statistics

Avg vol (3-month) 3827.71k
Avg vol (10-day) 3970.41k
Shares outstanding 550.2M
Implied shares outstanding 6N/A
Float 845.09M
% held by insiders 115.01%
% held by institutions 187.95%
Shares short (28 Apr 2022) 42.44M
Short ratio (28 Apr 2022) 44.71
Short % of float (28 Apr 2022) 45.10%
Short % of shares outstanding (28 Apr 2022) 44.59%
Shares short (prior month 30 Mar 2022) 42.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 3.55%
Operating margin (ttm)7.06%

Management effectiveness

Return on assets (ttm)4.65%
Return on equity (ttm)4.48%

Income statement

Revenue (ttm)276.98M
Revenue per share (ttm)5.56
Quarterly revenue growth (yoy)71.20%
Gross profit (ttm)252.23M
EBITDA 22.58M
Net income avi to common (ttm)9.84M
Diluted EPS (ttm)0.28
Quarterly earnings growth (yoy)-84.20%

Balance sheet

Total cash (mrq)176.1M
Total cash per share (mrq)3.48
Total debt (mrq)29.21M
Total debt/equity (mrq)12.21
Current ratio (mrq)5.77
Book value per share (mrq)4.67

Cash flow statement

Operating cash flow (ttm)25.49M
Levered free cash flow (ttm)28.52M